Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Tech Connect, Vol. 6, Issue 17: FDA approves Vanderbilt-designed Indego® exoskeleton for clinical and personal use

    ... in tumors to determine how they will respond to certain anti-cancer drugs. The company intends to sell its diagnostics services on a ... companies and academic institutions looking to develop oncology treatments. Frontier Diagnostics (Foxx), founded by Dr. Richard ...

    steelmk - 11/10/2016 - 7:45am

  2. FIRST Diagnostics wins 2015 Tech Venture Challenge

    ... FIRST Diagnostics, a company centered around a COX-2 Cancer Diagnostic developed by Vanderbilt Professor Larry Marnett, Ph.D., was ... has high potential for translation to clinical use as a cancer diagnostic for improved tumor detection in humans. ...

    nbmas - 10/02/2015 - 10:43am

  3. La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

    ... infection, chronic immune activation and malignancy), cancer, cardiovascular diseases and inflammatory bowel disease. After ... pathway in stem cell maturation, cholesterol homeostasis and cancer. Dr. Lindsley is a Professor of Pharmacology and Chemistry at ...

    steelmk - 10/02/2015 - 10:45am

  4. Therapeutic Antibody Discovery and Development Event

    ... clinical practice for the treatment of diseases ranging from cancer to autoimmune and infectious diseases. The Office of the Vice Provost ...

    sommers - 02/21/2019 - 9:51am

  5. Energetic gene switch

    ... numerous genes. MGO concentrations are elevated in cancer, cardiovascular disease, diabetes and renal disease, particularly in ...

    sommers - 02/21/2019 - 9:51am

  6. Study reveals new targets to inhibit pulmonary fibrosis

    ... to bleomycin, a drug in use since the 1960s to treat cancer. Pursuing cues from an assortment of previous findings, the new ...

    sommers - 02/21/2019 - 9:51am

  7. Discovery could lead to neutralizing West Nile virus

    ... white blood cells from the subjects were fused to myeloma (cancer) cells to produce fast-growing “factories” of specific, monoclonal ...

    sommers - 02/21/2019 - 9:51am

  8. Team isolates antibodies that neutralize GI bug norovirus

    ... By fusing the white blood cells to fast-growing myeloma (cancer) cells, the researchers can produce large quantities of “monoclonal” ...

    sommers - 02/21/2019 - 9:51am

  9. Enabling Innovation Initiative Series

    ... Associate Director, Koch Institute for Integrative Cancer Research Co-Founder, Chairman of the SAB, Adimab LLC   ...

    mullerg - 03/16/2018 - 1:28pm

  10. Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders

    ... focused on the identification of novel therapies for cancer. About Neuropsychiatric Disorders Brain or ...

    sommers - 02/21/2019 - 9:51am